文献速递生殖医学

高龄产妇非整倍体植入前遗传学诊断的体外受精:一项随机对照研究

In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study.
PubMed 文献 · Fertil Steril · 2017-04-19

这项多中心随机对照研究纳入38至41岁高龄产妇,比较植入前遗传学诊断非整倍体筛查(PGD-A)组与对照组的囊胚移植结局。PGD-A组首次移植后每移植和每患者分娩率均显著更高,流产率更低,实现活产所需平均移植次数和妊娠时间更短,但研究结束6个月后累计分娩率无显著差异。

要点

  • PGD-A组首次移植后每移植分娩率52.9% vs 对照组24.2%,每患者36.0% vs 21.9%。
  • PGD-A组流产率2.7% vs 对照组39.0%,平均移植次数1.8 vs 3.7。
  • 研究结束6个月后每患者累计分娩率无显著差异。

核心结论

  • PGD-A在首次胚胎移植的临床结局上优于对照组,并大幅降低流产率、缩短妊娠时间。

研究设计与样本

  • 多中心随机对照试验,设PGD-A组(囊胚移植)和对照组(不进行PGD-A的囊胚移植)。
  • 共招募326例符合纳入标准的患者,205例完成研究(PGD-A组100例,对照组105例)。
  • 干预包括第3天胚胎活检、微阵列比较基因组杂交、囊胚移植和玻璃化冷冻。

主要发现

  • PGD-A组移植率显著低于对照组(68.0% vs 90.5%)。
  • PGD-A组流产率显著低于对照组(2.7% vs 39.0%)。
  • 首次移植尝试后每移植分娩率PGD-A组显著高于对照组(52.9% vs 24.2%),每患者分娩率也显著更高(36.0% vs 21.9%)。
  • 研究结束6个月后每患者累计分娩率无显著差异。
  • 每活产所需平均移植次数PGD-A组低于对照组(1.8 vs 3.7),妊娠时间也更短(7.7 vs 14.9周)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the clinical value of preimplantation genetic diagnosis for aneuploidy screening (PGD-A) in women of advanced maternal age (AMA; between 38 and 41 years). DESIGN: This was a multicenter, randomized trial with two arms: a PGD-A group with blastocyst transfer, and a control group with blastocyst transfer without PGD-A. SETTING: Private reproductive centers. PATIENT(S): A total of 326 recruited patients fit the inclusion criteria, and 205 completed the study (100 in the PGD-A group and 105 in the control group). INTERVENTION(S): Day-3 embryo biopsy, array comparative genomic hybridization, blastocyst transfer, and vitrification. MAIN OUTCOME MEASURE(S): Primary outcomes were delivery and live birth rates in the first transfer and cumulative outcome rates. RESULT(S): The PGD-A group exhibited significantly fewer ETs (68.0% vs. 90.5% for control) and lower miscarriage rates (2.7% vs. 39.0% for control). Delivery rate after the first transfer attempt was significantly higher in the PGD-A group per transfer (52.9% vs 24.2%) and per patient (36.0% vs. 21.9%). No significant differences were observed in the cumulative delivery rates per patient 6 months after closing the study. However, the mean number of ETs needed per live birth was lower in the PGD-A group compared with the control group (1.8 vs. 3.7), as was the time to pregnancy (7.7 vs. 14.9 weeks). CONCLUSION(S): Preimplantation genetic diagnosis for aneuploidy screening is superior compared with controls not only in clinical outcome at the first ET but also in dramatically decreasing miscarriage rates and shortening the time to pregnancy.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Rubio C, Bellver J, Rodrigo L, et al. In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study. Fertil Steril. 2017. PMID: 28433371. doi:10.1016/j.fertnstert.2017.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。